1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMultiple Sclerosis Research Program, Investigator-Initiated Research Award is sponsored by U.S. Department of Defense (CDMRP). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
## View Grant Opportunity DoD Multiple Sclerosis Research Program, Investigator-Initiated Research Award Dept.
of the Army -- USAMRAA Document Type:Grants Notice Funding Opportunity Number:W81XWH-17-MSRP-IIRA Funding Opportunity Title:DoD Multiple Sclerosis Research Program, Investigator-Initiated Research Award Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Grant Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards:4 Assistance Listings:12.
420 -- Military Medical Research and Development Cost Sharing or Matching Requirement:No Original Closing Date for Applications:Oct 05, 2017 Current Closing Date for Applications:Oct 05, 2017 Archive Date:Nov 04, 2017 Estimated Total Program Funding:$ 6,000,000 Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: ## Additional Information Agency Name:Dept.
of the Army -- USAMRAA Description:The Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials.
The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project. Link to Additional Information:[](https://www.
grants. gov/search-results-detail/293758) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact:
According to the current listing, eligibility includes: Independent investigators at all levels; Assistant Professors within 5 years of appointment for New Investigator option. Confirm the full requirements in the official notice before applying.
The current listing shows $1,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Multiple Sclerosis Research Program, Investigator-Initiated Research Award is funded by U.S. Department of Defense (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article